Sequential vs upfront intensified neoadjuvant chemotherapy in patients with large resectable and/or locally advanced breast cancer. The INTENS Study.
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms INTENS
- 10 Jun 2017 Biomarkers information updated
- 10 Jul 2013 Primary endpoint 'Complete-pathological-response-rate' has not been met.
- 10 Jul 2013 Results published in the European Journal of Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History